menu search

Blueprint medicines announces inducement grants under nasdaq listing rule 5635(c)(4)

CAMBRIDGE, Mass., Oct. 5, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically def...

October 5, 2021, 4:01 pm


Search within

Pages Search Results: